By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Uterotonic agents > Hemabate > Hemabate Side Effects
Uterotonic agents

Hemabate Side Effects

Note: This document contains side effect information about carboprost. Some dosage forms listed on this page may not apply to the brand name Hemabate.

Applies to carboprost: intramuscular solution.

Warning

Intramuscular route (Solution)

Carboprost tromethamine, like other potent oxytocic agents, should be used only with strict adherence to recommended dosages. Carboprost tromethamine should be used by medically trained personnel in a hospital which can provide immediate intensive care and acute surgical facilities.

Serious side effects of Hemabate

Along with its needed effects, carboprost (the active ingredient contained in Hemabate) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking carboprost:

Less common or rare

  • Fast or slow heartbeat
  • headache (severe and continuing)
  • hives or skin rash
  • increased pain of the uterus
  • pale, cool, blotchy skin on arms or legs
  • pressing or painful feeling in chest
  • shortness of breath
  • swelling of face, inside the nose, and eyelids
  • tightness in chest
  • trouble in breathing
  • weak or absent pulse in arms or legs
  • wheezing

Check with your doctor as soon as possible if any of the following side effects occur while taking carboprost:

  • Constipation
  • pain or inflammation at place of injection
  • tender or mildly bloated abdomen or stomach

Other side effects of Hemabate

Some side effects of carboprost may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Diarrhea
  • nausea
  • vomiting

Less common or rare

  • Chills or shivering
  • dizziness
  • fever (temporary)
  • flushing or redness of face
  • headache
  • stomach cramps or pain

This procedure may result in some effects, which occur after the procedure is completed, that need medical attention. Check with your doctor if you notice any of the following:

  • Chills or shivering (continuing)
  • fever (continuing)
  • foul-smelling vaginal discharge
  • increase in uterus bleeding
  • pain in lower abdomen

For Healthcare Professionals

Applies to carboprost: injectable solution.

General

-Contractile effect on smooth muscle, nausea, vomiting, diarrhea, increased temperature and flushing are the most frequent adverse reactions observed.

-Adverse effects of this drug are generally transient and reversible when therapy ends.

-Endometritis, retained placental fragments, and excessive uterine bleeding were the most common complications after discharge from the hospital.[Ref]

Transient pyrexia may be due to the effect of carboprost on hypothalamic thermoregulation. Temperature elevation exceeding 2 degrees Fahrenheit have been reported in approximately 12.5% of the patients who received the recommended dosage regimen. In all cases, temperature returned to normal when therapy ended.[Ref]

Gastrointestinal

Pretreatment or concurrent administration of antiemetic and antidiarrheal drugs considerably decreases the very high incidence of gastrointestinal side effects that are common with all prostaglandins used for abortion.[Ref]

Very common (10% or more): Vomiting and diarrhea (66%), nausea (33%)

Uncommon (0.1% to 1%): Hematemesis, upper abdominal pain, dry mouth

Frequency not reported: Epigastric pain, excessive thirst, taste alterations, gagging

Postmarketing reports: Retching[Ref]

Other

Very common (10% or more): Body temperature increased (12%)

Uncommon (0.1% to 1%): Vertigo, tinnitus

Frequency not reported: Retained placental fragment

Postmarketing reports: Chest pain, asthenia[Ref]

Cardiovascular

The degree of hypertension was moderate and it is not certain as to whether it was due to a direct effect of carboprost (the active ingredient contained in Hemabate) or a return to a status of pregnancy associated hypertension manifested by the correction of hypovolemic shock.[Ref]

Common (1% to 10%): Flushing, hot flushing, chills

Uncommon (0.1% to 1%): Septic shock, tachycardia

Frequency not reported: Hypertension, shivering

Postmarketing reports: Palpitations[Ref]

Genitourinary

When carboprost (the active ingredient contained in Hemabate) was used for abortion, the most common complications which required additional treatment after discharge from the hospital were endometritis, retained placental fragments, and excessive uterine bleeding which was reported to have occurred in approximately 2% of patients.[Ref]

Common (1% to 10%): Endometritis, uterine hemorrhage, retained placenta or membranes

Uncommon (0.1% to 1%): Urinary tract infection, uterine rupture, uterine cervical laceration, pelvic pain

Frequency not reported: Dysmenorrhea-like pain, uterine disorder, perforated uterus, uterine sacculation, uterine rupture[Ref]

Nervous system

Common (1% to 10%): Headaches

Uncommon (0.1% to 1%): Syncope vasovagal, dizziness, dystonia, paresthesia, somnolence, dysgeusia, lethargy

Frequency not reported: Drowsiness, faintness, lightheadedness

Postmarketing reports: Nervousness, syncope[Ref]

Respiratory

Common (1% to 10%): Cough

Uncommon (0.1% to 1%): Asthma, respiratory distress, dyspnea, hyperventilation, wheezing, hiccups

Frequency not reported: Nosebleed, bronchospasm, pharyngeal edema, upper respiratory tract infection, pulmonary edema, shortness of breath, fullness of throat

Postmarketing reports: Chocking sensation, epistaxis, dry throat[Ref]

Dermatologic

Uncommon (0.1% to 1%): Hyperhidrosis

Frequency not reported: Diaphoresis

Postmarketing reports: Rash[Ref]

Local

Uncommon (0.1% to 1%): Injection side pain[Ref]

Musculoskeletal

Uncommon (0.1% to 1%): Torticollis, back pain, myalgia

Frequency not reported: Breast tenderness, muscular pain, muscle spasms, leg cramps

Postmarketing reports: Blepharospasm[Ref]

Ocular

Uncommon (0.1% to 1%): Blurred vision, eye pain

Frequency not reported: Twitching eyelids[Ref]

Psychiatric

Uncommon (0.1% to 1%): Sleep disorders

Postmarketing reports: Anxiety[Ref]

Endocrine

Frequency not reported: Thyroid storm

Postmarketing reports: Thyrotoxic crisis[Ref]

Hypersensitivity

Postmarketing reports: Anaphylactic reactions, anaphylactic shock, anaphylactoid reaction, angioedema[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by